-
1
-
-
0028156958
-
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey
-
KESSLER RC, MCCONGALE KA, ZHAO S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51: 8-19.
-
(1994)
Arch Gen Psychiatry
, vol.51
, pp. 8-19
-
-
Kessler, R.C.1
Mccongale, K.A.2
Zhao, S.3
-
2
-
-
0035186927
-
Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey
-
FARRELL M, HOWES S, BEBBINGTON P et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001;179:432-437.
-
(2001)
Br J Psychiatry
, vol.179
, pp. 432-437
-
-
Farrell, M.1
Howes, S.2
Bebbington, P.3
-
3
-
-
0021188136
-
Historical context, major objectives, and study population characteristics
-
The NIMH Epidemiologic Catchment Area program
-
REGIER DA, MYERS JK, KRAMER M et al. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984;41:934-941.
-
(1984)
Arch Gen Psychiatry
, vol.41
, pp. 934-941
-
-
Regier, D.A.1
Myers, J.K.2
Kramer, M.3
-
4
-
-
0032813828
-
Dopamine transporter availability and depressive symptoms alcohol withdrawal
-
LAINE TP, AHONEN A, RASANEN P, TIIHONEN J. Dopamine transporter availability and depressive symptoms alcohol withdrawal. Psychiatry Res 1999;90:153-157.
-
(1999)
Psychiatry Res
, vol.90
, pp. 153-157
-
-
Laine, T.P.1
Ahonen, A.2
Rasanen, P.3
Tiihonen, J.4
-
5
-
-
0025373450
-
Pharmacological treatment of substance-abusing schizophrenic patients
-
SIRIS SG. Pharmacological treatment of substance-abusing schizophrenic patients. Shizophr Bull 1990;16: 111-122.
-
(1990)
Shizophr Bull
, vol.16
, pp. 111-122
-
-
Siris, S.G.1
-
6
-
-
0028918837
-
Clozapine decreases smoking in patients with chronic schizophrenia
-
MCEVOY J, FREUDENREICH O, MCGEE M, VANDERZWAAG C, LEVIN E, ROSE J. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 1995;37:550-552.
-
(1995)
Biol Psychiatry
, vol.37
, pp. 550-552
-
-
Mcevoy, J.1
Freudenreich, O.2
Mcgee, M.3
Vanderzwaag, C.4
Levin, E.5
Rose, J.6
-
7
-
-
0033782696
-
Abuse potential of anticholinergics
-
DOSE M, TEMPEL HD. Abuse potential of anticholinergics. Pharmacopsychiatry 2000;33 (Suppl. 1):43-46.
-
(2000)
Pharmacopsychiatry
, vol.33
, Issue.SUPPL. 1
, pp. 43-46
-
-
Dose, M.1
Tempel, H.D.2
-
8
-
-
0035878562
-
A neurobiological basis for substance abuse comordibity in schizophrenia
-
CHAMBERS RA, KRYSTAL JH, SELF DW. A neurobiological basis for substance abuse comordibity in schizophrenia. Biol Psychiatry 2001;50:71-83.
-
(2001)
Biol Psychiatry
, vol.50
, pp. 71-83
-
-
Chambers, R.A.1
Krystal, J.H.2
Self, D.W.3
-
9
-
-
0002541114
-
Overview of treatment modalities for dual diagnosis patients: Pharmacotherapy, psychotherapy, and 12-step programmes
-
Kranzler H, Rounsaville B, eds. New York, NY: Marcel Dekker Inc.
-
WEISS R, NAJAVITS L. Overview of treatment modalities for dual diagnosis patients: Pharmacotherapy, psychotherapy, and 12-step programmes. In: KRANZLER H, ROUNSAVILLE B, eds. Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders. New York, NY: Marcel Dekker Inc., 1998:87.
-
(1998)
Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders
, pp. 87
-
-
Weiss, R.1
Najavits, L.2
-
10
-
-
0029095766
-
Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic
-
SAXON AJ, CALSYN DA. Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic. Am J Drug Alcohol Abuse 1995;21:303-313.
-
(1995)
Am J Drug Alcohol Abuse
, vol.21
, pp. 303-313
-
-
Saxon, A.J.1
Calsyn, D.A.2
-
11
-
-
0029867460
-
Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial
-
MCGRATH PJ, NUNES EV, STEWART JW, GOLDMAN D, AGOSTI V, OCEPEK-WELIKSON K, QUITKIN FM. Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Arch Gen Psychiatry 1996;53:232-240.
-
(1996)
Arch Gen Psychiatry
, vol.53
, pp. 232-240
-
-
Mcgrath, P.J.1
Nunes, E.V.2
Stewart, J.W.3
Goldman, D.4
Agosti, V.5
Ocepek-Welikson, K.6
Quitkin, F.M.7
-
12
-
-
0025891475
-
Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use
-
NUNES EV, QUITKIN FM, BRADY R, STEWART JW. Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use. Am J Psychiatry 1991;148:667-669.
-
(1991)
Am J Psychiatry
, vol.148
, pp. 667-669
-
-
Nunes, E.V.1
Quitkin, F.M.2
Brady, R.3
Stewart, J.W.4
-
13
-
-
0030860546
-
Fluoxetine in depressed alcoholics. A double blind placebo-controlled trial
-
CORNELIUS JR, SALLOUM IM, CORNELIUS MD et al. Fluoxetine in depressed alcoholics. A double blind placebo-controlled trial. Arch Gen Psychiatry 1997;54: 700-705.
-
(1997)
Arch Gen Psychiatry
, vol.54
, pp. 700-705
-
-
Cornelius, J.R.1
Salloum, I.M.2
Cornelius, M.D.3
-
14
-
-
0031024436
-
The self-medication hypothesis of substance use disorders: A reconsideration and recent applications
-
KHANTZIAN EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997;4:231-244.
-
(1997)
Harv Rev Psychiatry
, vol.4
, pp. 231-244
-
-
Khantzian, E.J.1
-
15
-
-
0025760581
-
Subjective experiences related to alcohol use among schizophrenics
-
NOORDSY DL, DRAKE RE, TEAGUE GB et al. Subjective experiences related to alcohol use among schizophrenics. J Nerv Ment Dis 1991;179:410-414.
-
(1991)
J Nerv Ment Dis
, vol.179
, pp. 410-414
-
-
Noordsy, D.L.1
Drake, R.E.2
Teague, G.B.3
-
17
-
-
0025356975
-
Prevalence of substance abuse in schizophrenia: Demographical clinical correlates
-
MUESER KT, YARNOLD PR, LEVINSON DF, SINGH H, BELLACK AS, KEE K, MORRISON RL, YADALAM KG. Prevalence of substance abuse in schizophrenia: demographical clinical correlates. Schizophr Bull, 1990;16: 31-56.
-
(1990)
Schizophr Bull
, vol.16
, pp. 31-56
-
-
Mueser, K.T.1
Yarnold, P.R.2
Levinson, D.F.3
Singh, H.4
Bellack, A.S.5
Kee, K.6
Morrison, R.L.7
Yadalam, K.G.8
-
18
-
-
0024504232
-
Effect of spontaneous ingestion of ethanol on brain dopamine metabolism
-
FADDA F, MOSCA E, COLOMBO G, GESSA GL. Effect of spontaneous ingestion of ethanol on brain dopamine metabolism. Life Sci, 1989;44:281-287.
-
(1989)
Life Sci
, vol.44
, pp. 281-287
-
-
Fadda, F.1
Mosca, E.2
Colombo, G.3
Gessa, G.L.4
-
19
-
-
0028952302
-
Nicotine dependence, midbrain dopamine systems and psychiatric disorders
-
NISSEL M, NOMIKOS GG, SVENSSON TH. Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharm Toxicol, 1995;76:157-162.
-
(1995)
Pharm Toxicol
, vol.76
, pp. 157-162
-
-
Nissel, M.1
Nomikos, G.G.2
Svensson, T.H.3
-
20
-
-
0347758858
-
Catecholamines their metabolites, and response to typical and atypical neuroleptics: Toward an understanding of the mechanisms of action of neuroleptic drugs
-
Friedhoff, AJ, Amin, F, eds. APA Press, Inc.
-
GREEN AL, TSUANG MT, SCHILDKRAUT JJ. Catecholamines, their metabolites, and response to typical and atypical neuroleptics: Toward an understanding of the mechanisms of action of neuroleptic drugs. In: FRIEDHOFF, AJ, AMIN, F, eds. Plasma Homovanillic Acid in Schizophrenia. APA Press, Inc.: 1997:61-77.
-
(1997)
Plasma Homovanillic Acid in Schizophrenia
, pp. 61-77
-
-
Green, A.L.1
Tsuang, M.T.2
Schildkraut, J.J.3
-
21
-
-
0031853426
-
Cannabiniod/ anandamide system and schizophrenia: Is there evidence for association?
-
SCHNEIDER U, LEWEKE FM, MUELLER-VAHL KR, EMRICH HM. Cannabiniod/ anandamide system and schizophrenia: is there evidence for association? Pharmacopsychiatry 1998;2 (Suppl. 31):110-113.
-
(1998)
Pharmacopsychiatry
, vol.2
, Issue.SUPPL. 31
, pp. 110-113
-
-
Schneider, U.1
Leweke, F.M.2
Mueller-Vahl, K.R.3
Emrich, H.M.4
-
22
-
-
0033519542
-
Elevated endogenous cannabiniods in schizophrenia
-
June 3
-
LEWEKE FM, FUIFFRIDA A, WURSTER U, EMRICH HM, PIOMELLI D. Elevated endogenous cannabiniods in schizophrenia. Neuroreport, 1999 June 3;10:1665-1669.
-
(1999)
Neuroreport
, vol.10
, pp. 1665-1669
-
-
Leweke, F.M.1
Fuiffrida, A.2
Wurster, U.3
Emrich, H.M.4
Piomelli, D.5
-
23
-
-
0035669358
-
Human psychopharmacology of Ecstasy (MDMA): A review of 15 years of empirical research
-
PARROTT AC. Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 2001;16:557-577.
-
(2001)
Hum Psychopharmacol
, vol.16
, pp. 557-577
-
-
Parrott, A.C.1
-
24
-
-
0036278962
-
Ecstasy-induced psychotic disorder: Six month follow-up study
-
LANDABASO MA, IRAURGI I, JIMENEZ-LERMA JM, CALLE R, SANZ J, GUTIERREZ-FRAILE M. Ecstasy-induced psychotic disorder: six month follow-up study. Eur Addict Res 2002;8:133-140.
-
(2002)
Eur Addict Res
, vol.8
, pp. 133-140
-
-
Landabaso, M.A.1
Iraurgi, I.2
Jimenez-Lerma, J.M.3
Calle, R.4
Sanz, J.5
Gutierrez-Fraile, M.6
-
25
-
-
0033955215
-
Effects of clozapine on substance use in patients with schizophrenic and schizoaffective disorder: A retrospective survey
-
ZIMMET SV, STROUS RD, BURGESS ES, KOHNSTAMM S, GREEN AI. Effects of clozapine on substance use in patients with schizophrenic and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol 2000;20: 94-98.
-
(2000)
J Clin Psychopharmacol
, vol.20
, pp. 94-98
-
-
Zimmet, S.V.1
Strous, R.D.2
Burgess, E.S.3
Kohnstamm, S.4
Green, A.I.5
-
26
-
-
0022899199
-
Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol
-
IMPERATO A, Di CHIARA G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharm Exp Ther 1986;239:219-228.
-
(1986)
J Pharm Exp Ther
, vol.239
, pp. 219-228
-
-
Imperato, A.1
Di Chiara, G.2
-
27
-
-
0034830198
-
A comparison of smoking behaviours between patients treated with risperidone
-
PROCYSHYN RM, IHSAN N, THOMPSON D. A comparison of smoking behaviours between patients treated with risperidone. Int Clin Psychopharmacol 2001;16: 291-294.
-
(2001)
Int Clin Psychopharmacol
, vol.16
, pp. 291-294
-
-
Procyshyn, R.M.1
Ihsan, N.2
Thompson, D.3
-
28
-
-
0033918990
-
The effects of clozapine on alcohol and drug use disorders and patients with schizophrenia
-
DRAKE RE, ZIE H, MCHUGO CJ, GREEN AI. The effects of clozapine on alcohol and drug use disorders and patients with schizophrenia. Schizophr Bull 2000;26: 441-449.
-
(2000)
Schizophr Bull
, vol.26
, pp. 441-449
-
-
Drake, R.E.1
Zie, H.2
Mchugo, C.J.3
Green, A.I.4
-
29
-
-
0002030793
-
Comorbidity of alcohol, drug, and psychiatric disorders
-
Kranzler H, Rounsaville B, eds. New York, NY: Marcel Dekker Inc.
-
HASIN D, NUNES E. Comorbidity of alcohol, drug, and psychiatric disorders. In: KRANZLER H, ROUNSAVILLE B, eds. Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders. New York, NY: Marcel Dekker Inc., 1998:1-30.
-
(1998)
Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders
, pp. 1-30
-
-
Hasin, D.1
Nunes, E.2
-
30
-
-
0035669490
-
Olanzapine treatment for patients with schizophrenia and substance abuse
-
LITTRELL KH, PETTY RG, HILLIGOSS NM, PEABODY CD, JOHNSON CG. Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat 2001;21:217-221.
-
(2001)
J Subst Abuse Treat
, vol.21
, pp. 217-221
-
-
Littrell, K.H.1
Petty, R.G.2
Hilligoss, N.M.3
Peabody, C.D.4
Johnson, C.G.5
-
31
-
-
0035542905
-
Risperidone in the treatment of psychotic patients with opiate abuse and dependence
-
CASAS M, GUTIERREZ M, GILBERT J, BOBES J, RONCERO C, OCTAVIO I. Risperidone in the treatment of psychotic patients with opiate abuse and dependence. Actas Esp Psiquiatr 2001;29:380-385.
-
(2001)
Actas Esp Psiquiatr
, vol.29
, pp. 380-385
-
-
Casas, M.1
Gutierrez, M.2
Gilbert, J.3
Bobes, J.4
Roncero, C.5
Octavio, I.6
-
32
-
-
0037333663
-
Alcohol cannabis use in schizophrenia: Effects of clozapine vs. risperidone
-
GREEN AI, BURGESS ES, DAWSON R, ZIMMET SV, STROUS RD. Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophr Res 2003;60:81-85.
-
(2003)
Schizophr Res
, vol.60
, pp. 81-85
-
-
Green, A.I.1
Burgess, E.S.2
Dawson, R.3
Zimmet, S.V.4
Strous, R.D.5
-
33
-
-
0036218499
-
Effects of major depression on remission and relapse of substance dependence
-
HASIN D, LIU X, NUNES E, MCCLOUD S, SAMET S, ENDICOTT J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry 2002;59:375-380.
-
(2002)
Arch Gen Psychiatry
, vol.59
, pp. 375-380
-
-
Hasin, D.1
Liu, X.2
Nunes, E.3
Mccloud, S.4
Samet, S.5
Endicott, J.6
-
35
-
-
0031693208
-
Dual diagnosis: A review of etiological theories
-
MUESER KT, DRAKE RE, WALLACH MA. Dual diagnosis: a review of etiological theories. Addict Behav 1998;23: 717-734.
-
(1998)
Addict Behav
, vol.23
, pp. 717-734
-
-
Mueser, K.T.1
Drake, R.E.2
Wallach, M.A.3
-
36
-
-
2542497995
-
Shared mechanisms in affective illness, epilepsy, and migraine
-
POST RM, SILBERSTEIN SD. Shared mechanisms in affective illness, epilepsy, and migraine. Neurology 1994;44 (Suppl. 7):S37-S47.
-
(1994)
Neurology
, vol.44
, Issue.SUPPL. 7
-
-
Post, R.M.1
Silberstein, S.D.2
-
37
-
-
0036497938
-
Relationship between blockade of dopamine transporters by methylphenidate and the increases in extracellular dopamine therapeutic implications
-
VOLKOW ND, WANG GJ, FOWLER JS et al. Relationship between blockade of dopamine transporters by methylphenidate and the increases in extracellular dopamine therapeutic implications. Synapse 2002;43:181-187.
-
(2002)
Synapse
, vol.43
, pp. 181-187
-
-
Volkow, N.D.1
Wang, G.J.2
Fowler, J.S.3
-
38
-
-
0033930105
-
Brain SPECT imagine of amphetamine-induced dopamine release in euthymic bipolar disorder patients
-
ANAND A, VERHOEFF P, SENECA N, ZOGHBI SS, SEIBYL JP, CHARNEY DS. Brain SPECT imagine of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 2000;157:1108-1114.
-
(2000)
Am J Psychiatry
, vol.157
, pp. 1108-1114
-
-
Anand, A.1
Verhoeff, P.2
Seneca, N.3
Zoghbi, S.S.4
Seibyl, J.P.5
Charney, D.S.6
-
39
-
-
0024605211
-
Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal
-
MALCOLM R, BALLENGER JC, STURGIS ET, ANTON R. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989;146:617-621.
-
(1989)
Am J Psychiatry
, vol.146
, pp. 617-621
-
-
Malcolm, R.1
Ballenger, J.C.2
Sturgis, E.T.3
Anton, R.4
-
40
-
-
0035226308
-
Valporic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
-
CD003196
-
MACRITCHIE KA, GEDDES JR, SCOTT J, HASLAM DR, GOODWIN GM. Valporic acid, valproate and divalproex in the maintenance treatment of bipolar disorder. Cochrane Database Syst Rev 2001;3:CD003196.
-
(2001)
Cochrane Database Syst Rev
, vol.3
-
-
Macritchie, K.A.1
Geddes, J.R.2
Scott, J.3
Haslam, D.R.4
Goodwin, G.M.5
-
41
-
-
0028948046
-
Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: A pilot study
-
BRADY KT, SONNE SC, ANTON R, BALLENGER JC. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry 1995;56:118-121.
-
(1995)
J Clin Psychiatry
, vol.56
, pp. 118-121
-
-
Brady, K.T.1
Sonne, S.C.2
Anton, R.3
Ballenger, J.C.4
-
42
-
-
0034992402
-
Use of antipsychotic drugs and lithium in mania
-
COOKSON J. Use of antipsychotic drugs and lithium in mania. Br J Psychiatry Suppl, 2001;41:s148-s156.
-
(2001)
Br J Psychiatry Suppl
, vol.41
-
-
Cookson, J.1
-
43
-
-
1542294435
-
Drug abuse and mood disorders
-
Kranzler H, Rounsaville B, eds. New York, NY: Marcel Dekker Inc.
-
HERSH D, MODESTO-LOWE V. Drug abuse and mood disorders. In: KRANZLER H, ROUNSAVILLE B, eds. Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders. New York, NY: Marcel Dekker Inc., 1998:177-201.
-
(1998)
Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders
, pp. 177-201
-
-
Hersh, D.1
Modesto-Lowe, V.2
-
45
-
-
0021710737
-
New insights and treatments: Opiate withdrawal and cocaine addiction
-
GOLD MS, DACKIS CA. New insights and treatments: opiate withdrawal and cocaine addiction. Clin Ther 1984;7:6-21.
-
(1984)
Clin Ther
, vol.7
, pp. 6-21
-
-
Gold, M.S.1
Dackis, C.A.2
-
46
-
-
0030009226
-
A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression
-
MASON BJ, KOCSIS JH, RITVO EC, CUTLER RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 1996;275:803-804.
-
(1996)
JAMA
, vol.275
, pp. 803-804
-
-
Mason, B.J.1
Kocsis, J.H.2
Ritvo, E.C.3
Cutler, R.B.4
-
47
-
-
0029905556
-
Dosing issues in the pharmacotherapy of alcoholism
-
MASON BJ. Dosing issues in the pharmacotherapy of alcoholism. Alcohol Clin Exp Res 1996;20 (Suppl. 7):10A-16A.
-
(1996)
Alcohol Clin Exp Res
, vol.20
, Issue.SUPPL. 7
-
-
Mason, B.J.1
-
48
-
-
0027263197
-
Imipramine treatment of alcoholism with comorbid depression
-
NUNES EV, McGRATH PJ, QUITKIN FM et al. Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 1993;150:963-965.
-
(1993)
Am J Psychiatry
, vol.150
, pp. 963-965
-
-
Nunes, E.V.1
Mcgrath, P.J.2
Quitkin, F.M.3
-
49
-
-
0028907519
-
Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
-
KRANZLER HR, BURLESON JA, KORNER P et al. Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 1995;152:391-397.
-
(1995)
Am J Psychiatry
, vol.152
, pp. 391-397
-
-
Kranzler, H.R.1
Burleson, J.A.2
Korner, P.3
-
50
-
-
0035427438
-
Fluoxetine treatment of cocaine-dependent patients with major depressive disorder
-
SCHMITZ JM, AVERILL P, STOTTS AL, MOELLER FG, RHOADES HM, GRABOWSKI J. Fluoxetine treatment of cocaine-dependent patients with major depressive disorder. Drug Alcohol Depend 2001;63:207-214.
-
(2001)
Drug Alcohol Depend
, vol.63
, pp. 207-214
-
-
Schmitz, J.M.1
Averill, P.2
Stotts, A.L.3
Moeller, F.G.4
Rhoades, H.M.5
Grabowski, J.6
-
51
-
-
0031798732
-
A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts
-
LANDABASO MA, IRAURGI I, JIMENEZ-LERMA JM, SANZ J et al. A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts. Addiction 1998;93:739-744.
-
(1998)
Addiction
, vol.93
, pp. 739-744
-
-
Landabaso, M.A.1
Iraurgi, I.2
Jimenez-Lerma, J.M.3
Sanz, J.4
-
52
-
-
0024591157
-
Desipramine facilitation of initial cocaine abstinence
-
GAWIN FH, KLEBER HD, BYCK R et al. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989;46:117-121.
-
(1989)
Arch Gen Psychiatry
, vol.46
, pp. 117-121
-
-
Gawin, F.H.1
Kleber, H.D.2
Byck, R.3
-
53
-
-
0026345451
-
Pharmacotherapy improves treatment outcome in depressed cocaine addicts
-
ZIEDONIS DM, KOSTEN TR. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoactive Drugs Dec 1991;23:417-425.
-
(1991)
J Psychoactive Drugs Dec
, vol.23
, pp. 417-425
-
-
Ziedonis, D.M.1
Kosten, T.R.2
-
54
-
-
0028924581
-
Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacology
-
CARROL KM, NICH C, ROUNSAVILLE BJ. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacology. J Nerv Ment Dis 1995;183:251-259.
-
(1995)
J Nerv Ment Dis
, vol.183
, pp. 251-259
-
-
Carrol, K.M.1
Nich, C.2
Rounsaville, B.J.3
|